Atlas Trials

Empagliflozin Effect on Glucose Toxicity

Clinical trial NCT03437330 · WITHDRAWN

Trial details

NCT number
NCT03437330
Sponsor
University Hospital Tuebingen
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type2 Diabetes Mellitus
Start date
2021-10-27
Primary completion
2023-05-03
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.